DeutschNewstral
Article
bizjournals.com on 2019-01-08 21:32
Catalent investing roughly $100M, adding 100 jobs to biologics operations in Madison
Related news
- Pfizer investing $100M in N.C. plant expansion, adding jobsbizjournals.com
- Pfizer investing $100M in Sanford plant expansion, adding jobsbizjournals.com
Catalent to invest $200 million to expand biologics capacityjournalrecord.com
Catalent to expand Wisconsin biomanufacturing operationSeattle Times- TCMO and CDMO biotechnology Market 2022 Development Plans, Global Growth Rate by Manufacturers | Lonza., Patheon, Catalent, Boehringer Ingelheim, Samsung Biologics and Samsung BioLogicsthetechtalk.org
- Nationwide investing $100M in startupsbizjournals.com
- LCMO and CDMO biotechnology Market 2021 Analysis by Size, Share, Growth, Trends up to 2027 | Patheon, Catalent, Samsung Biologics, Lonza.liverpoolstudentmedia.com
- Emerson investing in $100M Sidney expansionbizjournals.com
- ServiceNow is investing $100M in Black communitiesbizjournals.com
- GIsrael biotech fund begins investing $100mglobes.co.il
- KBiologics Drug Development Market Size and Growth 2021-2027 | Major Players – Abbvie, Allergan, Boehringer Ingelheim, Charles River Laboratories, Catalent, Lonza Group, Amgen, Sanofiksusentinel.com
- Tech leaders investing, adding jobs in Midwestbizjournals.com
Southern Motion investing $20M, adding 600 jobsDJournalnow- Madison's Venture Investors raises roughly 75% of $100M goal for new health care fundbizjournals.com
- CMulticoin Capital Is in Talks to Sell Roughly $100M FTX Bankruptcy Claim: Sourcecoindesk.com
- NNetflix investing $100M to build 6 sound stages in NYCnypost.com